Pseudohypoaldosteronism Type II-Reference-Cited by-同舟云学术

Pseudohypoaldosteronism Type II

Published:2014-04 Issue:4 Volume:63 Page:648-654
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Healy John K.¹

Affiliation:

1. From the Princess Alexandra Hospital Brisbane, Brisbane, Queensland, Australia; and Renal Unit, Royal Brisbane Hospital, Brisbane, Queensland, Australia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.113.02187

Reference80 articles.

1. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism

2. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism

3. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption

4. Hypertension and hyperpotassaemia without renal disease in a young male.;Paver WK;Med J Aust,1964

5. Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldosteron und Niere – eine komplexe Interaktion;Journal für Endokrinologie, Diabetologie und Stoffwechsel;2024-03-15

2. Identification of a novel KLHL3-interacting motif in the C-terminal region of WNK4;Biochemical and Biophysical Research Communications;2023-08

3. Aldosterone defects in infants and young children with hyperkalemia: A single center retrospective study;Frontiers in Pediatrics;2023-01-16

4. Importance of cascade family screening and precision medicine for patients with familial hyperkalaemia: a case report;Hong Kong Medical Journal;2022-10-12

5. The Post-Translational Modification Networking in WNK-Centric Hypertension Regulation and Electrolyte Homeostasis;Biomedicines;2022-09-02